DIANA ISAACS: Open Payments
NPI 1265050538 · AUSTINTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,481 in 241 payments from 18 companies in 2025. Trend: 2023 $3,580 · 2024 $20,212 · 2025 $21,481
Speaker / faculty: $15,800Food & beverage: $4,646Travel & lodging: $923Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 66 | $17,573 |
| E.R. Squibb & Sons, L.L.C. | 22 | $565 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $444 |
| Otsuka America Pharmaceutical, Inc. | 20 | $389 |
| Neurocrine BioSciences, Inc. | 15 | $372 |
| Teva Pharmaceuticals USA, Inc. | 21 | $330 |
| Sequel Med Tech, LLC | 2 | $313 |
| Axsome Therapeutics, Inc. | 15 | $312 |
| Vanda Pharmaceuticals Inc. | 16 | $308 |
| Lundbeck LLC | 19 | $261 |
Products named: VRAYLAR, COBENFY, REXULTI, CAPLYTA, INGREZZA, TWIIST, Auvelity, FANAPT.
Industry payments across OH — which companies pay providers there.
